Brain Biotechnology Research And In (0RFI)
LSE
Year End September 29 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 68.5M | 74.46M | 66.12M | 72.15M | 77.74M | 77.99M | 70.94M | 88.74M |
Total Current Assets | 53.56M | 41.02M | 30.96M | 33.08M | 39.11M | 30.39M | 25.48M | 45.66M |
Cash and Equivalents | 38.95M | 25.54M | 15.16M | 18.94M | 24.55M | 8.44M | 5.35M | 27.17M |
Total Non-Current Assets | 47.36M | 30.64M | 17.09M | 26.14M | 41.83M | 34.25M | 23.01M | 13.89M |
Total Liabilities | 21.14M | 43.83M | 49.03M | 46.01M | 35.91M | 43.74M | 47.92M | 74.85M |
Total Current Liabilities | 8.43M | 10.97M | 14.87M | 12.36M | 11.34M | 21.39M | 17.48M | 25.01M |
Total Non-Current Liabilities | 20.9M | 58.21M | 58.93M | 60.97M | 42.24M | 37.62M | 54.7M | 67.17M |
Total Equity | 47.36M | 30.64M | 17.09M | 26.14M | 41.83M | 34.25M | 23.01M | 13.89M |
Common Equity | 18.06M | 18.06M | 18.06M | 19.86M | 21.85M | 21.85M | 21.85M | 21.85M |
Retained Earnings | -47.74M | -55.79M | -70.65M | -77.5M | -79.51M | -85.2M | -94.16M | -105.49M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.